Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias

NCT00562757 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2007-11-22

No results posted yet for this study

Summary

The purpose of this study is to determine how well the device predicts susceptability to potentially lethal ventricular arrhythmias.

Conditions

Sponsors & Collaborators

  • Harbinger Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Harold Hoium, MBA · Harbinger Medical, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Completion
2009-10-31

Countries

  • United States
  • Germany
  • Norway
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00562757 on ClinicalTrials.gov